Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geza Acs

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesotheliomaAlbert Y Chu, Leslie A Litzky, Theresa L Pasha, et al.
The American Journal of Pathology|March 4, 2005
Functional erythropoietin autocrine loop in melanomaSuresh M Kumar, Geza Acs, Dong Fang, et al.
Clinical Breast Cancer|April 6, 2006
Repeat operative sentinel lymph node biopsyBenjamin M Jackson, Samuel Kim, Rebecca Davidson, et al.
The American Journal of Pathology|March 7, 2009
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cellsGyorgy Paragh, Suresh M Kumar, Zsuzsa Rakosy, et al.
Gynecologic Oncology|July 30, 2005
Erythropoietin receptor function and expression in epithelial ovarian carcinomaJohn W McBroom, Geza Acs, G Scott Rose, et al.
The American Journal of Surgical Pathology|January 2, 2007
Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinomaGeza Acs, Kimberly L Dumoff, Lawrence J Solin, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinomaAhmed Mohyeldin, Huasheng Lu, Clifton Dalgard, et al.
Journal of Cancer Epidemiology|August 29, 2012
Treatment Choices Based on OncotypeDx in the Breast Oncology Care SettingTeri L Malo, Isaac Lipkus, Tobi Wilson, et al.
The American Journal of Surgical Pathology|July 29, 2003
Microglandular adenosis with transition into adenoid cystic carcinoma of the breastGeza Acs, Jean F Simpson, Ira J Bleiweiss, et al.
Sarcoma|June 8, 2011
Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumorMarilyn M Bui, Gang Han, Geza Acs, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2004
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesotheliomaAlbert Y Chu, Leslie A Litzky, Theresa L Pasha, et al.
The American Journal of Pathology|March 4, 2005
Functional erythropoietin autocrine loop in melanomaSuresh M Kumar, Geza Acs, Dong Fang, et al.
Clinical Breast Cancer|April 6, 2006
Repeat operative sentinel lymph node biopsyBenjamin M Jackson, Samuel Kim, Rebecca Davidson, et al.
The American Journal of Pathology|March 7, 2009
RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cellsGyorgy Paragh, Suresh M Kumar, Zsuzsa Rakosy, et al.
Gynecologic Oncology|July 30, 2005
Erythropoietin receptor function and expression in epithelial ovarian carcinomaJohn W McBroom, Geza Acs, G Scott Rose, et al.
The American Journal of Surgical Pathology|January 2, 2007
Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinomaGeza Acs, Kimberly L Dumoff, Lawrence J Solin, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinomaAhmed Mohyeldin, Huasheng Lu, Clifton Dalgard, et al.
Journal of Cancer Epidemiology|August 29, 2012
Treatment Choices Based on OncotypeDx in the Breast Oncology Care SettingTeri L Malo, Isaac Lipkus, Tobi Wilson, et al.
The American Journal of Surgical Pathology|July 29, 2003
Microglandular adenosis with transition into adenoid cystic carcinoma of the breastGeza Acs, Jean F Simpson, Ira J Bleiweiss, et al.
Sarcoma|June 8, 2011
Connexin 43 is a potential prognostic biomarker for ewing sarcoma/primitive neuroectodermal tumorMarilyn M Bui, Gang Han, Geza Acs, et al.
Pageof 7